X

Xilio Therapeutics Inc
NASDAQ:XLO

Watchlist Manager
Xilio Therapeutics Inc
NASDAQ:XLO
Watchlist
Price: 0.6619 USD -0.47% Market Closed
Market Cap: 34.7m USD

Wall Street
Price Targets

XLO Price Targets Summary
Xilio Therapeutics Inc

Wall Street analysts forecast XLO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XLO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

Lowest
Price Target
2.02 USD
205% Upside
Average
Price Target
2.04 USD
208% Upside
Highest
Price Target
2.1 USD
217% Upside
Xilio Therapeutics Inc Competitors:
Price Targets
COYA
Coya Therapeutics Inc
200% Upside
SYNACT
SynAct Pharma AB
11% Upside
688278
Xiamen Amoytop Biotech Co Ltd
22% Upside
ARGX
argenx SE
16% Upside
KALV
Kalvista Pharmaceuticals Inc
108% Upside
CAPR
Capricor Therapeutics Inc
75% Upside
ORY
Oryzon Genomics SA
130% Upside
145020
Hugel Inc
60% Upside

Revenue
Forecast

Revenue Estimate
Xilio Therapeutics Inc

The compound annual growth rate of Xilio Therapeutics Inc's revenue for the next 4 years is -12%.

N/A
Past Growth
-12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Xilio Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Xilio Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XLO's stock price target?
Price Target
2.04 USD

According to Wall Street analysts, the average 1-year price target for XLO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

What is Xilio Therapeutics Inc's Revenue forecast?
Projected CAGR
-12%

The compound annual growth rate of Xilio Therapeutics Inc's revenue for the next 4 years is -12%.

Back to Top